IMCR - Utang jangka cendhak marang modal Immunocore

The share price of Immunocore Holdings plc (IMCR) visualized below on the GURU.Markets platform is 0.00. The company, led by Bakhtiar Karimi, is implementing cutting-edge developments in cancer therapy. The logistics model relies on a network of global distribution centers to maintain the quality of perishable biologics. Business stability is guaranteed by a staff of leading T-cell experts and an aggressive search for specialized clinical trial professionals.

This indicator determines the proportion of short-term borrowings relative to equity, assessing the liquidity and financial stability of the balance sheet. By analyzing the trend of short-term liabilities to equity, an investor can gauge the company's dependence on rapid refinancing, which is critically important for Immunocore Holdings plc (IMCR), given the colossal costs of multi-year clinical trials and the launch of complex TCR drug production.